Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: the Efficacy and Safety of Ondansetron Oral Soluble Pellicles [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of ondansetron oral soluble pellicles for nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron oral soluble pellicles (ondansetron)

Snippet

Sponsor: The First Affiliated Hospital of Xinxiang Medical College | Conditions: Nausea and Vomiting | Phase 3 | Status: UNKNOWN